U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906627) titled 'Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)' on Feb. 21.
Brief Summary: IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease(CKD)
Type 2 DM
Type 2 Diabetes Mellitus (T2DM)
Intervention:
OTHER: (IRIS-CKD Screening Program): Home Kit
All participants approached for enrollment in Program 1 will receive National Kidney Foundational educational materials related to CK...